Global Rheumatic Disorders Drugs Market Grow at (CAGR) of 4.46% to $80.04 billion in 2024

Global Rheumatic Disorders Drugs Market to 2024 research report covers key diseases of rheumatic disorders, market size, therapy area overview, etiology, Epidemiology Patterns and Forecasts - Prevalence and Patient Segmentation and key marketed products.

Pune, India - February 12, 2019 /MarketersMedia/ —

Global Rheumatic Disorders Drugs Market to 2024 - Increased Uptake of IL Inhibitors and JAK Inhibitors to Drive Growth as TNF Inhibitors Face Patent Expiry research report added to ReportsnReports online database.
The rheumatic disorder therapy area is multi-disciplinary in nature and encompasses conditions that affect joints, connective tissue, ligaments, tendons, cartilage, bone and muscle and which are characterized by chronic pain and a consequent reduction in function and motion. The majority of rheumatic disorders are treated using largely genericized pain management drugs, and there are no cures for any of the key indications, leaving a large unmet need for better disease-modifying drugs to be developed.

Get Discount on Rheumatic Disorders Drugs Market Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=1854866

This report covers all rheumatic disorders, but there is a particular focus on five key diseases, rheumatoid arthritis, osteoarthritis, osteoporosis, systemic lupus erythematosus and psoriatic arthritis, as these conditions have the largest pipelines within the therapy area.

The market size for rheumatic disorder therapeutics was $58.97 billion in 2017 and is expected to grow at a compound annual growth rate (CAGR) of 4.46% to $80.04 billion in 2024.

Scope

- How is the rheumatic disorders market landscape expected to change?
- Which drugs will face patent expiry, biosimilar competition and decreasing revenue over the forecast period?
- Overall, there are 1,069 products in the rheumatic disorder pipeline, how does the composition of the pipeline compare with that of the existing market?
- Which molecular targets are most prominent within the pipeline and how do the key indications differ in terms of their pipeline composition?
- The market size for rheumatic disorder therapeutics is expected to grow, from $58.97 billion in 2017 to $80.04 billion in 2024, at a CAGR of 4.46%. Which products will contribute to market growth most, and which will achieve blockbuster status?
- What types of companies are involved in the rheumatic disorder therapy area?
- Will the current market leaders retain their dominance over the forecast period?
- How many strategic consolidations have been completed in the past decade and which types of assets attract the largest deal values?

Reasons to Buy:
This report will allow you to -
- Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis and the treatment options available at each stage of diagnosis for the five key indications
- Understand how the patent expiries of the key, blockbuster anti-TNF drugs will affect the Rheumatic Disorder Drug Market
- Identify trends and developments in the rheumatic disorder pipeline and consider market opportunities and potential risks by examining trends in clinical trial duration and size, as well as clinical trial failure rates
- Identify which two drug classes will see particularly strong market growth over the forecast period
- See how or if the companies marketing anti-TNF drugs facing patent expiry will be able to offset biosimilar erosion
- Identify commercial opportunities in the rheumatic disorder deal landscape by analyzing trends in licensing and co-development deals

Direct Purchase of Rheumatic Disorders Drugs Market Research Report at https://www.reportsnreports.com/purchase.aspx?name=1854866

Table of Contents:
1. Introduction
2. Key Marketed Products
3. Pipeline Landscape Assessment
4. Multi-scenario Market Forecast to 2024
5. Company Analysis and Positioning
6. Strategic Consolidations
7. Appendix

Contact Info:
Name: Vishal Kalra
Email: Send Email
Organization: ReportsnReports
Website: https://www.reportsnreports.com/reports/1854866-global-rheumatic-disorders-drugs-market-to-2024-increased-uptake-of-il-inhibitors-and-jak-inhibitors-to-drive-growth-as-tnf-inhibitors-face-patent-expiry.html

Source URL: https://marketersmedia.com/global-rheumatic-disorders-drugs-market-grow-at-cagr-of-446-to-8004-billion-in-2024/481750

Source: MarketersMedia

Release ID: 481750

Latest News

Global stocks mixed after Wall Street rebound

Aug 22, 2019

BEIJING — Global stock markets were mixed Thursday following Wall Street's rebound as investors looked ahead to a speech by the U.S. Federal Reserve chairman for clues about possible interest rate cuts. Investor reaction was muted following Wednesday's release of notes from the latest Fed meeting showing conflicting opinions about rates. Benchmarks in London and Frankfurt declined in early trading. Hong Kong closed down while Shanghai and Tokyo advanced. Investors are looking to Chairman Jerome Powell's speech Friday for guidance about whether the Fed might cut rates at its next meeting in September. The Fed cut its key policy rate...

Off the hook: California king salmon rebounds after drought

Aug 22, 2019

SAN FRANCISCO — California fishermen are reporting one of the best salmon fishing seasons in years, thanks to heavy rain and snow that ended the state's historic drought. It's a sharp reversal for chinook salmon, also known as king salmon. The iconic fish helps sustain many Pacific Coast fishing communities. A marine scientist with California's fish and wildlife agency says commercial catches have so far surpassed official preseason forecasts by roughly 50%. The salmon rebound comes after three years of extremely low catches resulting from poor ocean conditions and California's five-year drought. This year's adult salmon are the first class...

Jet catches fire in Northern California; 10 aboard unhurt

Aug 22, 2019

OROVILLE, Calif. — All 10 people aboard a small jet escaped injury Wednesday after the aircraft aborted its takeoff at a small Northern California airport, went off the runway and burst into flames, officials said. The pilot of the twin-engine Cessna Citation jet aborted its takeoff at Oroville Municipal Airport for unknown reasons shortly before noon, Federal Aviation Administration spokesman Ian Gregor said. The plane was carrying two pilots and eight passengers, and "all were accounted for, no injuries," said Joe Deal, Oroville's fire and police chief. The jet had complications during takeoff that resulted in its catching fire, he...

Trump to sign student debt forgiveness for disabled veterans

Aug 22, 2019

LOUISVILLE, Ky. — President Donald Trump on Wednesday is expected to direct his administration to permanently forgive student loan debt held by disabled veterans. Trump was to sign the order after he addresses the AMVETS convention in Louisville, the White House said. In prepared remarks, Trump said his order would direct the Department of Education to "eliminate every penny of federal student loan debt owed by American veterans who are completely and permanently disabled." The administration says just half of the roughly 50,000 disabled veterans who are qualified to have their federal student loan debt forgiven have received the benefit...

Mexico concerned by dangerous natural gas thefts

Aug 22, 2019

MEXICO CITY — Mexico's president is warning against a growing trend in which thieves drill illegal taps into pipelines carrying natural gas. At least two large-scale leaks have occurred in recent weeks at illegally tapped pipelines in central Mexico. President Andres Manuel López Obrador said Wednesday that "lately we have been seeing gas thefts, which is something very dangerous." His administration has cracked down on the more common crime of stealing gasoline and diesel from fuel pipelines. While gasoline thefts remain far more common, at least some thieves have turned to stealing LP gas, which is used for cooking and...

Search

Deck Biz is an intelligent platform providing international and regional business news updates. You won’t get these insights elsewhere other than Deck Biz.

Contact us: sales@deckbiz.com